Lazard Asset Management
GH icon

Lazard Asset Management’s Guardant Health GH Stock Holding History

Lazard Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.16M Sell
45,000
-50,000
-53% -$5.02M 0.01% 610
2025
Q4 		$9.7M Buy
+95,000
New +$8.5M 0.02% 419

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management's GH Position: Q1 2026 in Review

Lazard Asset Management reduced its Guardant Health (GH) stake by 20% in Q1 2026, selling an estimated $619K and leaving 24,419 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #834.

Lazard Asset Management first reported a position in GH in Q2 2020 and has held it in 23 quarters since. The position peaked at $11.8M in Q3 2022. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Lazard Asset Management held 24,419 shares of Guardant Health worth $2.26M as of Q1 2026.
  • Lazard Asset Management sold 6,166 Guardant Health shares in Q1 2026, an estimated $619K.
  • Guardant Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #834 holding.
  • Lazard Asset Management first reported a position in Guardant Health in Q2 2020 and has held it in 23 quarters since.
  • Lazard Asset Management's Guardant Health position peaked at $11.8M in Q3 2022.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.